Showing results (181-190 of 206) with videos related to
Sort By:
Pageof 21
Immunity|November 17, 2016
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization BreadthJinghe Huang, Byong H Kang, Elise Ishida, et al.Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.Immunity|March 18, 2018
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.Plos Computational Biology|February 4, 2015
Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trialPaul T Edlefsen, Morgane Rolland, Tomer Hertz, et al.Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.Plos Pathogens|September 18, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral familiesMatthew J Vukovich, Andrea R Shiakolas, Jared Lindenberger, et al.Cell Reports|January 28, 2023
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donorKelsey A Pilewski, Steven Wall, Simone I Richardson, et al.Pageof 21